Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 101–200 of 1,000
Multiple Sclerosis and Regulatory T Cells
Costantino, C. M., Baecher-Allan, C., & Hafler, D. A. (2008) · Journal of Clinical Immunology · doi:10.1007/s10875-008-9236-x · Cited by 165
“In humans, FoxP3 is expressed strongly in CD4CD25 T cells and at low levels in activated CD4 T cells [53], although FoxP3 expression has also been reported in a small fraction of the CD25, CD25, and CD8 T-cell subsets.”
BackgroundKmieciak, M., Gowda, M., Graham, L., Godder, K., Bear, H. D., Marincola, F. M., & Manjili, M. H. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-89 · Cited by 167
The effect of ageing on human lymphocyte subsets: comparison of males and females
Yan, J., Greer, J. M., Hull, R., O'Sullivan, J. D., Henderson, R. D., Read, S. J., & McCombe, P. A. (2010) · Immunity & Ageing · doi:10.1186/1742-4933-7-4 · Cited by 166
“Recently transcription factor Foxp3 has been recognized as the most specific marker of T regulatory cells [53,54], although Foxp3 also appears to be increased in most activated human CD4 + T cells [39, 40 ].”
BackgroundVitamin D3 targets epidermal and dermal dendritic cells for induction of distinct regulatory T cells
van der Aar, A. M. G., Sibiryak, D. S., Bakdash, G., van Capel, T. M. M., van der Kleij, H. P. M., Opstelten, D.-J. E., Teunissen, M. B. M., Kapsenberg, M. L., & de Jong, E. C. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.01.068 · Cited by 164
Manigold, T., & Racanelli, V. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70289-x · Cited by 164
Betts, G., Jones, E., Junaid, S., El-Shanawany, T., Scurr, M., Mizen, P., Kumar, M., Jones, S., Rees, B., Williams, G., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300970 · Cited by 165
FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability
León, B., Bradley, J. E., Lund, F. E., Randall, T. D., & Ballesteros-Tato, A. (2014) · Nature Communications · doi:10.1038/ncomms4495 · Cited by 160
Lineage stability and phenotypic plasticity of Foxp3+ regulatory T cells
Hori, S. (2014) · Immunological Reviews · doi:10.1111/imr.12175 · Cited by 158
Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment
(2015) · Advances in Cancer Research · doi:10.1016/bs.acr.2015.05.001 · Cited by 159
Immune suppression and reversal of the suppressive tumor microenvironment
Shimizu, K., Iyoda, T., Okada, M., Yamasaki, S., & Fujii, S.-I. (2018) · International Immunology · doi:10.1093/intimm/dxy042 · Cited by 157
Human regulatory T cells and autoimmunity
Costantino, C. M., Baecher‐Allan, C. M., & Hafler, D. A. (2008) · European Journal of Immunology · doi:10.1002/eji.200738104 · Cited by 158
“In humans, FoxP3 is expressed strongly in CD4+CD25high T cells and at low levels in activated CD4+ T cells [11], although FoxP3 expression has also been reported in a small fraction of the CD25−, CD25intermediate, and CD8+ T cell subsets.”
BackgroundICOS+ Tregs: A Functional Subset of Tregs in Immune Diseases
Li, D.-Y., & Xiong, X. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02104 · Cited by 172
“It is inevitable that a small group of activated effector T cells are included in CD25FOXP3 T cells, (22, 23) which could be IL-17 or IFN-γ positive, and this proportion could be even higher in inflammatory environment.”
BackgroundHimmel, M. E., Hardenberg, G., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02939.x · Cited by 155
Ronchetti, S., Ricci, E., Petrillo, M. G., Cari, L., Migliorati, G., Nocentini, G., & Riccardi, C. (2015) · Journal of Immunology Research · doi:10.1155/2015/171520 · Cited by 152
Tumors establish resistance to immunotherapy by regulating T reg recruitment via CCR4
Marshall, L. A., Marubayashi, S., Jorapur, A., Jacobson, S., Zibinsky, M., Robles, O., Hu, D. X., Jackson, J. J., Pookot, D., Sanchez, J., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-000764 · Cited by 169
Natural Regulatory T Cells and Persistent Viral Infection
Li, S., Gowans, E. J., Chougnet, C., Plebanski, M., & Dittmer, U. (2008) · Journal of Virology · doi:10.1128/jvi.01768-07 · Cited by 149
Mjösberg, J., Svensson‐Arvelund, J., Johansson, E., Hellström, L., Casas, R., Jenmalm, M. C., Boij, R., Matthiesen, L., Jönsson, J., Berg, G. E., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803654 · Cited by 164
Suppression assays with human T regulatory cells: A technical guide
McMurchy, A. N., & Levings, M. K. (2012) · European Journal of Immunology · doi:10.1002/eji.201141651 · Cited by 147
Dissecting the Heterogeneity in T-Cell Mediated Inflammation in IBD
Tindemans, I., Joosse, M. E., & Samsom, J. N. (2020) · Cells · doi:10.3390/cells9010110 · Cited by 162
“Lower or transient levels of Foxp3 expression do not give rise to suppressive Treg and are detected in human non-regulatory recently activated T-cells [96].”
BackgroundGellatly, K. J., Strassner, J. P., Essien, K., Refat, M. A., Murphy, R. L., Coffin-Schmitt, A., Pandya, A. G., Tovar-Garza, A., Frisoli, M. L., Fan, X., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd8995 · Cited by 141
“This method is advantageous due to the fact that FOXP3 alone is often insufficient to fully classify a T cell as a Treg, because effector T cells (Teffs) can express FOXP3 under certain conditions (22).”
MethodLin, S. ‐., Chen, K. ‐., Lin, C., Kuo, C. ‐., Ling, Q., & Chan, C. ‐. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01882.x · Cited by 142
Histone/protein deacetylases and T-cell immune responses
Akimova, T., Beier, U. H., Liu, Y., Wang, L., & Hancock, W. W. (2012) · Blood · doi:10.1182/blood-2011-10-292003 · Cited by 140
Inflammation negatively regulates FOXP3 and regulatory T-cell function via DBC1
Gao, Y., Tang, J., Chen, W., Li, Q., Nie, J., Lin, F., Wu, Q., Chen, Z., Gao, Z., Fan, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421463112 · Cited by 140
“Foxp3 protein is expressed transiently in CD4CD25 effector T cells upon T-cell receptor (TCR) stimulation but does not generate T cells with suppressive activity (8, 9).”
BackgroundFritzsching, B., Fellenberg, J., Moskovszky, L., Sápi, Z., Krenacs, T., Machado, I., Poeschl, J., Lehner, B., Szendrõi, M., Bosch, A. L., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990800 · Cited by 140
Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination
Joosten, S. A., & Ottenhoff, T. H. M. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.07.017 · Cited by 139
“However, in human beings, not all FoxP3 cells are Tregs [8] and FoxP3 is transiently upregulated also on activated non-regulatory T cells [9], implying that FoxP3 is not a very specific marker for human Tregs.”
BackgroundAfzali, B., Mitchell, P., Lechler, R. I., John, S., & Lombardi, G. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04038.x · Cited by 156
Naji, A., Rond, S. L., Dürrbach, A., Krawice-Radanne, I., Créput, C., Daouya, M., Caumartin, J., LeMaoult, J., Carosella, E. D., & Rouas‐Freiss, N. (2007) · Blood · doi:10.1182/blood-2007-04-083139 · Cited by 136
Moncrieffe, H., Nistala, K., Kamhieh, Y., Evans, J., Eddaoudi, A., Eaton, S., & Wedderburn, L. R. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0803474 · Cited by 137
Surveillance of Antigen-Presenting Cells by CD4+CD25+ Regulatory T Cells in Autoimmunity
André, S., Tough, D. F., Lacroix‐Desmazes, S., Kaveri, S. V., & Bayry, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080987 · Cited by 160
Toulza, F., Heaps, A., Tanaka, Y., Taylor, G. P., & Bangham, C. R. M. (2008) · Blood · doi:10.1182/blood-2007-10-118539 · Cited by 136
Martin, F., Ladoire, S., Mignot, G., Apétoh, L., & Ghiringhelli, F. (2010) · Oncogene · doi:10.1038/onc.2010.174 · Cited by 155
“Under these conditions, FOXP3 upregulation can be only transient and insufficient to confer immunosuppressive functions to activated T cells (Gavin et al., 2006; Wang et al., 2007).”
BackgroundRegulation of IL-17 in Human CCR6+ Effector Memory T Cells
Liu, H., & Rohowsky-Kochan, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7948 · Cited by 131
Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs
Akimova, T., Ge, G., Golovina, T., Mikheeva, T., Wang, L., Riley, J. L., & Hancock, W. W. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.04.018 · Cited by 131
“Second, unlike murine cells, human CD4+CD25- (and CD8+) effector cells transiently express FOXP3+ upon T cell activation [24].”
BackgroundTaflin, C., Miyara, M., Nochy, D., Valeyre, D., Naccache, J., Altare, F., Peyron, P., Badoual, C., Bruneval, P., Haroche, J., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080580 · Cited by 131
Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential
Spitz, C., Winkels, H., Bürger, C., Weber, C., Lutgens, E., Hansson, G. K., & Gerdes, N. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2080-2 · Cited by 137
“Commitment of T cells to the Treg lineage appears to be independent of Foxp3 expression [89, 101].”
BackgroundLocal and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
Mittal, S., Marshall, N. A., Duncan, L., Culligan, D. J., Barker, R. N., & Vickers, M. A. (2008) · Blood · doi:10.1182/blood-2007-08-105395 · Cited by 131
CD8+ Tregs in lupus, autoimmunity, and beyond
Dinesh, R. K., Skaggs, B. J., Cava, A. L., Hahn, B. H., & Singh, R. P. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.03.006 · Cited by 133
“While Foxp3 expression has been suggested as a unique marker for the identification of both CD4+ Tregs and CD8+ Tregs, the finding that TCR activation also upregulates Foxp3 expression in cells without significant regulatory capacity [10,50-52] diminishes enthusiasm for this idea.”
BackgroundThe Presence of Foxp3 Expressing T Cells Within Grafts of Tolerant Human Liver Transplant Recipients
Li, Y., Zhao, X., Cheng, D., Haga, H., Tsuruyama, T., Wood, K. J., Sakaguchi, S., Tanaka, K., Üemoto, S., & Koshiba, T. (2008) · Transplantation · doi:10.1097/tp.0b013e31818febc4 · Cited by 134
Leptin and regulatory T-lymphocytes in idiopathic pulmonary arterial hypertension
Huertas, A., Tu, L., Gambaryan, N., Girerd, B., Perros, F., Montani, D., Fabre, D., Fadel, E., Eddahibi, S., Cohen-Kaminsky, S., et al. (2012) · European Respiratory Journal · doi:10.1183/09031936.00159911 · Cited by 127
Akimova, T., Kamath, B. M., Goebel, J. W., Meyers, K. E. C., Rand, E. B., Hawkins, A., Levine, M. H., Bucuvalas, J. C., & Hancock, W. W. (2012) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2012.04269.x · Cited by 126
“To assess contamination by CD4+CD25+CD127+ activated Teffs, we analyzed FOXP3+ and FOXP3- cells within CD4+CD25+ isolates.”
BackgroundInfluentialLow-strength T-cell activation promotes Th17 responses
Purvis, H. A., Stoop, J. N., Mann, J., Woods, S., Kozijn, A. E., Hambleton, S., Robinson, J. H., Isaacs, J. D., Anderson, A. E., & Hilkens, C. M. U. (2010) · Blood · doi:10.1182/blood-2010-03-272153 · Cited by 126
Zhang, B., Zhang, X., Tang, F. L., Zhu, L., Liu, Y., & Lipsky, P. E. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083543 · Cited by 123
Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells
Anderson, A. E., Sayers, B. L., Haniffa, M. A., Swan, D. J., Diboll, J., Wang, X.-N., Isaacs, J. D., & Hilkens, C. M. U. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107744 · Cited by 125
“The exact reason for this discrepancy is unclear but may be linked to the recent finding that in humans, FoxP3 is not exclusive to Tregs and is induced in all proliferating T cells [33, 34].”
BackgroundCasares, N., Rudilla, F., Arribillaga, L., Llopiz, D., Riezu-Boj, J. I., Lozano, T., López-Sagaseta, J., Guembe, L., Sarobe, P., Prieto, J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001114 · Cited by 124
“It has been described that anti-CD3 stimulation of human effector CD4 T cells induced a transient upregulation of FOXP3 that, although it did not confer immunosuppressive activity to the T cell, was strongly associated with hyporesponsiveness of activated T cells to subsequent stimulation (36).”
BackgroundInduced and natural regulatory T cells in human cancer
Whiteside, T. L., Schuler, P., & Schilling, B. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.707184 · Cited by 124
Hoek, A., Rutten, V. P. M. G., Kool, J., Arkesteijn, G. J. A., Bouwstra, R., Rhijn, I. V., & Koets, A. P. (2008) · Veterinary Research · doi:10.1051/vetres:2008044 · Cited by 127
“Our data therefore indicate that co-expression on T cells of CD4+CD25high and endogenous Foxp3, at least in cattle, is not exclusive for functional bovine regulatory T-cells, as has recently also been described in humans [41].”
BackgroundZoso, A., Mazza, E. M. C., Bicciato, S., Mandruzzato, S., Bronte, V., Serafini, P., & Inverardi, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201444522 · Cited by 123
GARP: a key receptor controlling FOXP3 in human regulatory T cells
Probst‐Kepper, M., Geffers, R., Kröger, A., Viegas, N., Erck, C., Hecht, H. ‐., Lünsdorf, H., Roubin, R., Moharregh‐Khiabani, D., Wagner, K., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00782.x · Cited by 123
“Following T-cell receptor (TCR) activation, human effector CD4 CD25 T (Th) cells up-regulate FOXP3 protein similar to other markers of T-cell activation including CD25 and CTLA4, and produce effector cytokines like IL-2 and interferon- despite the presence of FOXP3 [11–13].”
BackgroundPrognostic significance of regulatory T cells in tumor
Wilke, C. M., Wu, K., Zhao, E., Wang, G., & Zou, W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25464 · Cited by 120
Day, C. L., Tameris, M., Mansoor, N., van Rooyen, M., de Kock, M., Geldenhuys, H., Erasmus, M., Makhethe, L., Hughes, E. J., Gelderbloem, S., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201208-1385oc · Cited by 120
“However, induction of Foxp3 expression after TCR cross-linking in vitro has been associated with attenuation of effector functions (30), and previous studies have indicated Foxp3 can regulate T-cell activation by inhibiting nuclear factor of activated T cells–mediated transcription (31, 32).”
BackgroundInsulin‐like growth factor‐1 stimulates regulatory Tcells and suppresses autoimmune disease
Bilbao, D., Luciani, L., Johannesson, B., Piszczek, A., & Rosenthal, N. (2014) · EMBO Molecular Medicine · doi:10.15252/emmm.201303376 · Cited by 119
“Whereas in humans, Foxp3 is not directly correlated with T-cell-mediated suppression (Wang et al, 2007), in the mouse, it is both necessary and sufficient for Treg development and function (Sakaguchi et al, 2007).”
BackgroundThe Role of the Thymus in Tolerance
Griesemer, A., Sorenson, E. C., & Hardy, M. A. (2010) · Transplantation · doi:10.1097/tp.0b013e3181e7e54f · Cited by 151
“In addition, the finding in humans that some markers of Tregs, such as FOXP3, cytotoxic T-lymphocyte antigen (CTLA) 4, and CD25, are shared by other T cells, which represent a stage in the differentiation of activated T cells that complicates the analysis of the importance of Tregs in humans when evaluated by markers…”
BackgroundOgongo, P., Tezera, L. B., Ardain, A., Nhamoyebonde, S., Ramsuran, D., Singh, A., Ngoepe, A., Karim, F., Naidoo, T., Khan, K., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci142014 · Cited by 128
“Although FoxP3 is associated with Tregs, it is also transiently upregulated on activated T cells (55).”
Regulatory T cells in the tumour microenvironment
Imianowski, C. J., Chen, Q., Workman, C. J., & Vignali, D. A. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00832-9 · Cited by 158
van Mierlo, G. J. D., Scherer, H. U., Hameetman, M., Morgan, M. E., Flierman, R., Huizinga, T. W. J., & Toes, R. E. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.5.2747 · Cited by 124
Self-citationBraudeau, C., Racapé, M., Giral, M., Louis, S., Moreau, A., Berthelot, L., Heslan, M., Ashton‐Chess, J., Soulillou, J., & Brouard, S. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00537.x · Cited by 116
The role of regulatory T-cells in glioma immunology
Ooi, Y. C., Tran, P., Ung, N. M., Thill, K., Trang, A., Fong, B., Nagasawa, D. T., Lim, M. K., & Yang, I. (2014) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2013.12.004 · Cited by 128
“[74] Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE.”
BackgroundRapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1
van Loosdregt, J., Brunen, D., Fleskens, V., Pals, C. E. G. M., Lam, E. W. F., & Coffer, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019047 · Cited by 116
“However, a small percentage of stimulated T cells express high and stable levels of Foxp3 and have also been demonstrated to be immune suppressive [27;28].”
BackgroundThe Duration of T Cell Stimulation Is a Critical Determinant of Cell Fate and Plasticity
Miškov-Živanov, N., Turner, M. S., Kane, L., Morel, P. A., & Faeder, J. R. (2013) · Science Signaling · doi:10.1126/scisignal.2004217 · Cited by 121
“An early increase in the number of Foxp3 cells after stimulation with a high dose of antigen was shown previously for human (68) and mouse (69) T cells.”
BackgroundRegulatory T‐cells in systemic lupus erythematosus and rheumatoid arthritis
Chavele, K.-M., & Ehrenstein, M. R. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.07.043 · Cited by 115
Yates, J. B., Rovis, F., Mitchell, P., Afzali, B., Tsang, J. Y., Garin, M. I., Lechler, R. I., Lombardi, G., & Garden, O. A. (2007) · International Immunology · doi:10.1093/intimm/dxm047 · Cited by 125
T regulatory cells in cancer: recent advances and therapeutic potential
Elkord, E., Alcantar-Orozco, E., Dovedi, S. J., Tran, D. Q., Hawkins, R. E., & Gilham, D. E. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.529126 · Cited by 121
“For example, induction of FoxP3 expression conferred a regulatory activity in stimulated human CD4CD25 T cells [109], while other reports showed that the induction of FoxP3 was not correlated with Treg characteristics [110,111].”
ResultSchmidt, A., Eriksson, M., Shang, M.-M., Weyd, H., & Tegnér, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148474 · Cited by 112
“Some studies demonstrated Treg phenotype or suppressive capacities of Foxp3+ activated human T cells [3,84] while others did not [4,85,86]; yet others did not observe activation-induced transient Foxp3 induction in human Tcons [87].”
BackgroundHuman macrophages induce CD4+Foxp3+ regulatory T cells via binding and re‐release of TGF‐β
Schmidt, A., Zhang, X., Joshi, R. N., Iqbal, S., Wahlund, C., Gabrielsson, S., Harris, R. A., & Tegnér, J. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.34 · Cited by 112
Saleh, R., Toor, S. M., Khalaf, S., & Elkord, E. (2019) · Vaccines · doi:10.3390/vaccines7040149 · Cited by 125
“FoxP3 expression can be induced transiently upon activation of T cells [41,42]; however, its expression is sustained in canonical Tregs.”
BackgroundDe Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid
Wang, J., Huizinga, T. W. J., & Toes, R. E. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901065 · Cited by 130
“Purified CD4 CD25 CD45RA naive, CD4 CD25 CD45RA memory effector cells and CD4 CD25 / T cells were activated with 5 g/ml plate-bound anti-CD3 (OKT-3; BD Biosciences), 1 g/ml soluble antiCD28 (CLB-CD28/1; Sanquin), and 50 or 300 (for CD4 CD25 / ) U/ml IL-2 for 5 days as described previously (28).”
ResultSelf-citationQuintana, F. J. (2013) · Immunology · doi:10.1111/imm.12046 · Cited by 110
Zanzi, D., Stefanile, R., Santagata, S., Iaffaldano, L., Iaquinto, G., Giardullo, N., Lania, G., Vigliano, I., Vera, A. R., Ferrara, K., et al. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.80 · Cited by 111
Napavichayanun, S., Yamdech, R., & Aramwit, P. (2016) · Archives of Dermatological Research · doi:10.1007/s00403-016-1621-3 · Cited by 110
“related with hypo-responsiveness of activated T cell which led to low inflammatory response [31].”
BackgroundBonelli, M. M., von Dalwigk, K., Savitskaya, A., Smolen, J. S., & Scheinecker, C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074690 · Cited by 109
Fernandez, M. A., Puttur, F. K., Wang, Y. M., Howden, W., Alexander, S. I., & Jones, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1556 · Cited by 109
Enhanced formation and survival of CD4+CD25hiFoxp3+T-cells in chronic lymphocytic leukemia
Jak, M., Mous, R., Remmerswaal, E. B. M., Spijker, R., Jaspers, A., Yagüe, A., Eldering, E., van Lier, R. A. W., & van Oers, M. H. J. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902803677 · Cited by 130
“Long-term maintenance of Foxp3 expression after activation would correlate with suppressive capacity [34].”
BackgroundRossetti, M. M., Spreafico, R., Saidin, S., Chua, C. J. H., Moshref, M., Leong, J. Y., Tan, Y. K., Thumboo, J., van Loosdregt, J., & Albani, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401145 · Cited by 111
“We measured the efficiency of FOXP3 induction (iTregs) or maintenance (eTregs) after a 24 h resting period to allow activationinduced FOXP3 expression to subside (14, 15).”
BackgroundMethodThe imbalance between regulatory and IL-17-secreting CD4+ T cells in lupus patients
Ma, J., Yu, J., Tao, X., Cai, L., Wang, J., & Zheng, S. G. (2010) · Clinical Rheumatology · doi:10.1007/s10067-010-1510-7 · Cited by 107
Self-citationOldham, K. A., Parsonage, G., Bhatt, R. I., Wallace, D. M. A., Deshmukh, N., Chaudhri, S., Adams, D. H., & Lee, S. P. (2012) · European Urology · doi:10.1016/j.eururo.2011.10.035 · Cited by 104
Podshivalova, K., & Salomon, D. R. (2013) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2013006858 · Cited by 104
Hou, T. Z., Verma, N., Wanders, J., Kennedy, A., Soskic, B., Janman, D., Halliday, N., Rowshanravan, B., Worth, A. J. J., Qasim, W., et al. (2017) · Blood · doi:10.1182/blood-2016-10-745174 · Cited by 112
Bailey, S. R., Nelson, M. H., Majchrzak, K., Bowers, J. S., Wyatt, M. M., Smith, A. S., Neal, L. R., Shirai, K., Carpenito, C., June, C. H., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01867-9 · Cited by 103
The Presence of IL-17 + /FOXP3 + Double-positive Cells in Periodontitis
Okui, T., Yudai, A. O. K. I., Ito, H., Honda, T., & Yamazaki, K. (2012) · Journal of Dental Research · doi:10.1177/0022034512446341 · Cited by 103
“In the present study, although some non-regulatory CD4+ T-cells transiently expressed FOXP3 following stimulation in vitro (Wang et al., 2007), the number of FOXP3+ cells was lower in GT T-cell lines than in PB T-cell lines.”
BackgroundChen, L., Yang, P., Zhou, H., He, H., Ren, X., Chi, W., Wang, L., & Kijlstra, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-1793 · Cited by 105
“A recent study has shown that FOXP3 is transiently expressed in polyclonally stimulated human CD4 CD25 T cells and that these activated cells do not have a suppressive function in vitro.(24) Although our study did not exclude the possibility that a slight contamination of activated CD4 CD25 T cells may exist and a min…”
ResultMoving to tolerance: Clinical application of T regulatory cells
McMurchy, A. N., Bushell, A., Levings, M. K., & Wood, K. J. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.001 · Cited by 109
“In addition, simple phenotypic analyses of circulating Tregs may not give clear results because FOXP3 does not exclusively identify Tregs in humans [27-31] and the presence of Treg in the graft rather than the periphery may be a better indicator of outcome [57, 138].”
BackgroundPost-translational modification networks regulating FOXP3 function
van Loosdregt, J., & Coffer, P. J. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.06.005 · Cited by 106
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
Datsi, A., & Sorg, R. V. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.770390 · Cited by 100
Docosahexaenoic acid reduces suppressive and migratory functions of CD4CD25 regulatory T-cells
Yessoufou, A., Plé, A., Moutairou, K., Hichami, A., & Khan, N. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m900101-jlr200 · Cited by 100
Laakso, S. M., Laurinolli, T.-T., Rossi, L. H., Lehtoviita, A., Sairanen, H. I., Perheentupa, J., Kekäläinen, E., & Arstila, T. P. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.07.008 · Cited by 105
Mathian, A., Parizot, C., Dorgham, K., Trad, S., Arnaud, L., Larsen, M., Miyara, M., Hié, M., Pietté, J. C., Francès, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200709 · Cited by 102
Jacobse, J., Li, J., Rings, E. H. H. M., Samsom, J. N., & Goettel, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.716499 · Cited by 108
“To identify human Treg cells by flow cytometry, a minimum set of cell surface markers consisting of CD3, CD4, CD25, CD127, and FOXP3 are used with Ki67 and CD45RA providing additional information about Treg cell proliferation and activation status (21, 22).”
BackgroundMethodTumor Microenvironment and Immune Escape
Ferrone, S., & Whiteside, T. L. (2007) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2007.08.004 · Cited by 99
Tiittanen, M., Westerholm‐Ormio, M., Verkasalo, M., Savilahti, E., & Vaarala, O. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03662.x · Cited by 100
Tang, T., Song, Y. S., Ding, Y., Liao, Y., Yu, X., Du, R. H., Xiao, H., Yuan, J., Zhou, Z.-H., Liao, M., et al. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m010876 · Cited by 98
Fayyad-Kazan, H., Rouas, R., Fayyad-Kazan, M., Badran, R., El Zein, N., Lewalle, P., Najar, M., Hamade, E., Jebbawi, F., Merimi, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337154 · Cited by 96
T cells out of control—impaired immune regulation in the inflamed joint
Wehrens, E. J., Prakken, B. J., & van Wijk, F. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.149 · Cited by 104
Langhans, B., Nischalke, H. D., Krämer, B., Hausen, A., Dold, L., van Heteren, P., Hüneburg, R., Nattermann, J., Strassburg, C. P., & Spengler, U. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.12.019 · Cited by 96
“Foxp3 expression is a key feature of Tregs but can also occur transiently on CD4 T cells upon activation [26].”
BackgroundRegulatory T Helper Cells in Pregnancy and their Roles in Systemic versus Local Immune Tolerance
Ernerudh, J., Berg, G. E., & Mjösberg, J. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01049.x · Cited by 108
Subcellular localization of FOXP 3 in human regulatory and nonregulatory T cells
Magg, T., Mannert, J., Ellwart, J. W., Schmid, I., & Albert, M. H. (2012) · European Journal of Immunology · doi:10.1002/eji.201141838 · Cited by 114
Longitudinal Analysis of the Human T Cell Response during Acute Hantavirus Infection
Lindgren, T., Ahlm, C., Mohamed, N., Evander, M., Ljunggren, H., & Björkström, N. K. (2011) · Journal of Virology · doi:10.1128/jvi.05548-11 · Cited by 101
“Since FoxP3 can be transiently expressed in nonregulatory activated CD4 T cells (41), in the current study, we used multiple phenotypic markers (FoxP3, CD25, and CD127) to ensure that we were studying T cells of a regulatory phenotype.”
MethodMiyara, M., Wing, K., & Sakaguchi, S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.001 · Cited by 106
Regulatory T cell function in autoimmune disease
Rajendiran, A., & Tenbrock, K. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100130 · Cited by 124
Santegoets, S. J. A. M., Turksma, A. W., Suhoski, M. M., Stam, A. G. M., Albelda, S., Hooijberg, E., Scheper, R. J., van den Eertwegh, A. J. M., Gerritsen, W. R., Powell, D. J., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-37 · Cited by 102
Harnessing Regulatory T Cells for Clinical Use in Transplantation: The End of the Beginning
Juvet, S., Whatcott, A., Bushell, A., & Wood, K. J. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12647 · Cited by 98
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.